Cargando…
Interface-Based Design of High-Affinity Affibody Ligands for the Purification of RBD from Spike Proteins
The outbreak of coronavirus disease 2019 (COVID-19) has sparked an urgent demand for advanced diagnosis and vaccination worldwide. The discovery of high-affinity ligands is of great significance for vaccine and diagnostic reagent manufacturing. Targeting the receptor binding domain (RBD) from the sp...
Autores principales: | Song, Siyuan, Shi, Qinghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489752/ https://www.ncbi.nlm.nih.gov/pubmed/37687186 http://dx.doi.org/10.3390/molecules28176358 |
Ejemplares similares
-
Affibody-Binding Ligands
por: Barozzi, Annalisa, et al.
Publicado: (2020) -
Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells
por: De March, Matteo, et al.
Publicado: (2022) -
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
por: Barton, Michael I, et al.
Publicado: (2021) -
Mutational scanning of spike RBD protein for enhanced ACE2 affinity emerging Southeast Asia in the late transmission phase
por: Kodchakorn, Kanchanok, et al.
Publicado: (2022) -
Implementation of Novel Affinity Ligand for Lentiviral Vector Purification
por: Moreira, Ana Sofia, et al.
Publicado: (2023)